Cronos Group (TSE:CRON) Given a C$4.50 Price Target at TD Securities

TD Securities set a C$4.50 price objective on Cronos Group (TSE:CRON) in a report released on Tuesday,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Separately, Canaccord Genuity Group set a C$4.25 price objective on shares of Cronos Group and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Cronos Group currently has an average rating of “Buy” and a consensus target price of C$4.38.

Cronos Group Stock Up 3.3%

Shares of TSE CRON opened at C$3.74 on Tuesday. The company has a market cap of C$1.43 billion, a price-to-earnings ratio of 34.00, a PEG ratio of 0.12 and a beta of 1.21. The company has a current ratio of 24.24, a quick ratio of 24.01 and a debt-to-equity ratio of 0.17. Cronos Group has a 12 month low of C$2.27 and a 12 month high of C$4.66. The stock has a 50-day moving average price of C$3.66 and a two-hundred day moving average price of C$3.60.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.